04.05.2024 |
EV-Based Nanocarriers for NF1 Therapies
04.05.2024 |
Pre-Clinical Development of AAV9-NF1 Gene Therapy for Neurofibromatosis Type 1
04.05.2024 |
Development of a Peptide that Restores the Mutant NF1-Ras Interaction
04.05.2024 |
Novel Vectors for Gene Therapies Targeting Primary Human Schwann Cells
04.05.2024 |
Nanoparticle Delivery of Therapeutic NF1 Signaling ERPs to Schwann Cells
04.05.2024 |
Optimization of Base and Prime Editing Strategies for NF1 Therapeutics
04.05.2024 |
Optimized AAV Vectors for Therapeutic Schwann Cell Targeting in NF1
04.05.2024 |
Testing the Efficacy of New NF1 Gene Therapy Candidates in Human Cell Types
04.05.2024 |
Exon Skipping to Treat NF1 – Phase B
04.05.2024 |
Targeted Delivery of Full Length NF1 cDNA Using Non-Viral Vectors
03.27.2024
Detroit Future City Releases New Report: “Keeping Your Family Home: Addressing the Challenges of Inherited Properties in Detroit”
Read
09.12.2024